Vivtex Corp. announced the deal with Novo Nordisk worth up to $2.1 billion to develop oral drugs for conditions like obesity and diabetes.

The British pharma giant is paying cash for a Montreal-Boston biotech developing a drug for a serious lung condition.

A new study uses physics to uncover why sneakers squeak on the basketball court. Scientists slid a shoe against a smooth ...

Today in Sports, February 26 - Roger Federer breaks 30-year record with 161st week at the top of the ATP rankings ...

SEATTLE (AP) — Hilary Knight doesn't want to let what she called a “distasteful” joke by President Donald Trump about the ...

A Mexican restaurant that's popular in Boston is taking over the Burlington space formerly occupied by Osterio Nino.

Crystal Palace boss Oliver Glasner has been speaking to the media before Thursday's Conference League play-off second leg ...

NAU women's basketball will honor three graduating student-athletes during its final home game of the season before starting ...

Power failures and waist-high canyons of snow bedeviled parts of the Northeast in the aftermath of a massive storm that dumped piles on streets and sidewalks from Maryland Maine, even ...